Anadolu Medical Center
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.
Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.
Turkish medical groups including Anadolu Medical Center and Memorial Health Group are recognised for treating rare tumours like chordoma. These centres use multidisciplinary teams of neurosurgeons and oncologists. They use technologies such as CyberKnife, TrueBeam STx, and MR-LINAC for precise treatment.
Bookimed Expert Insight: While many private clinics offer radiotherapy, Anadolu Medical Center stands out for rare cases. It holds OECI and IASIOS certifications, which are strict European standards for interventional oncology. This suggests a higher level of oversight for complex sarcomas than standard JCI-only facilities.
Patient Consensus: Patients suggest focusing on Istanbul and Ankara for complex surgeries where specialists are most concentrated. It is important to confirm experience in skull-base or spinal sarcoma resection. This is particularly important when discussing cases in Turkey.
Turkish JCI-accredited centres manage chordoma using multidisciplinary teams of neurosurgeons and radiation oncologists. Specialist facilities like Anadolu Medical Center and Memorial Sisli Hospital use technologies including TrueBeam STx and CyberKnife to treat these rare bone tumours. Specialists such as Prof. Dr. Sefik Igdem explicitly list chordoma management within their expertise.
Bookimed Expert Insight: While many centres treat general brain tumours, look for specialists with explicit rare-sarcoma credentials. Prof. Dr. Sefik Igdem and Assoc. Prof. Abdullah Sakin are among the few who specifically mention chordoma in their clinical records. Choosing a centre like Anadolu Medical Center adds another layer of security. Its affiliation with Johns Hopkins Medicine means protocols for rare bone tumours meet international standards.
Patient Consensus: Patients in Turkey emphasise finding a named specialist with documented rare-tumour experience rather than just selecting a large hospital. They recommend asking doctors directly about the number of chordoma surgeries they have performed and how they coordinate post-operative radiation.
Turkish medical centres use multidisciplinary teams and formal tumour boards to treat chordoma. Specialists like neurosurgeons, radiation oncologists, and pathologists collaborate to manage these complex cases. JCI-accredited facilities such as Memorial Göztepe Hospital explicitly use this approach. This provides comprehensive care for rare spinal and cranial tumours.
Bookimed Expert Insight: Turkish oncology leaders often hold international credentials from the American Society of Clinical Oncology (ASCO). For example, Dr Mustafa Solak and Dr Yusuf Acikgoz have trained at top US institutions like MD Anderson. This means patients receive care following the same international protocols used in Australia. They do so within a more integrated private hospital system.
Patient Consensus: Patients note that large Turkish private hospitals provide easier access to multiple specialists under one roof. They recommend checking if surgeons have specific chordoma experience through international directories. Patients should do this before starting treatment in Turkey.
Chordoma is a rare, slow-growing bone cancer typically found at the skull base or spine. Turkish specialists treat it using endoscopic skull base surgery and high-precision radiation. Leading JCI-accredited centres in Istanbul offer TrueBeam STx technology. This targets residual tumours with sub-millimetre accuracy.
Bookimed Expert Insight: Turkish oncology centres like Hisar Hospital and Anadolu Medical Center serve many patients annually. Their volumes range from over 65,000 to 250,000. This massive volume allows specialists to maintain skills in rare sarcomas. A consultation costs around A$140 to A$210. However, the real value lies in the multidisciplinary tumour boards. These include neurosurgeons, radiation oncologists, and pathologists for every case.
Patient Consensus: Patients note that finding a surgeon with specific chordoma experience is vital. This is more important than a general cancer centre. Those travelling to Turkey emphasise that private tertiary hospitals offer reassuring collaborations. These are with major American medical institutions.
International patients choose Turkey for chordoma treatment due to high-precision radiation technologies and specialised neurosurgical teams. Leading facilities hold Joint Commission International (JCI) accreditation. They offer systems like MR-LINAC and TrueBeam STx. These tools are essential for treating rare skull base and spinal tumours safely.
Bookimed Expert Insight: Turkish oncology centres like Hisar Hospital Intercontinental serve over 250,000 patients annually. This massive volume allows specialists to see rare chordoma cases more frequently than Australian doctors. This experience is vital for complex skull base surgeries where preserving neurological function is the priority.
Patient Consensus: Patients seek centres with high case volumes to manage complex anatomy and recurrence risks effectively. They value finding multidisciplinary teams in Turkey that coordinate surgery and radiation in one location.
Turkish oncology centres provide multidisciplinary rehabilitation following chordoma treatment. This focuses on neurological recovery and spinal stability. Patients access robotic systems, specialised pain management, and neuro-oncology support at JCI-accredited facilities. Major Istanbul hospitals integrate these services to manage complex post-surgical needs and long-term recovery.
Bookimed Expert Insight: Turkish hospitals like Hisar Hospital Intercontinental offer diagnostics such as 3 Tesla MRI and MR-LINAC. However, formal inpatient rehabilitation is often separate from acute surgical care. Patients should confirm if their clinic includes on-site physiotherapy. Data shows major networks, such as Anadolu Medical Center, often provide better follow-up care integration. They do so through dedicated international patient coordinators. Anadolu Medical Center serves 65,000 patients annually.
Patient Consensus: Patients in Turkey find that hiring a private caregiver is the most practical way. It helps manage daily hygiene and nutrition during recovery. They note that personal responsiveness from the surgeon via mobile often helps. It provides more immediate support than formal institutional rehabilitation systems.
Turkish chordoma care combines multidisciplinary rehabilitation within JCI-accredited hospital networks. Specialist units provide neuro-rehabilitation, robotic-assisted therapy, and targeted pain management. Recovery protocols focus on spinal stabilisation and functional mobility. These services are integrated into major centres like Anadolu Medical Center and Memorial Healthcare Group.
Bookimed Expert Insight: Turkish oncology centres that prioritise international patients, like Anadolu Medical Center, use multidisciplinary tumour boards. These boards plan rehabilitation before surgery starts. This approach often includes early mobilisation protocols. In these, surgeons remain directly reachable via messaging apps for immediate post-discharge guidance. This informal but highly responsive supportive care model bridges the gap. It connects hospital discharge and the long flight back to Australia.
Patient Consensus: Patients find that recovery in Turkey focuses on early, careful walking. It also includes self-managed care in nearby hotels. Many emphasise the importance of having a travel companion. They also stress the need for supportive garments like corsets during the first 20 days post-surgery.